Microbial and Human Determinants of the Onset of IBD Flares

Status unconfirmed

Conditions studied: Ulcerative Colitis, Crohn Disease, Irritable Bowel, Crohns Disease Aggravated, Crohn Disease in Remission

In brief

This is a longitudinal, observational study that aims to identify the microbial and human molecular triggers of IBD flares via stool, saliva, and blood metatranscriptomes, whole blood proteome, and collected clinical metadata. This study is direct to participant and will not utilize clinical sites.

Key facts

Study ID

NCT05463900

Run by

Viome

People needed

2000

Starts

2022-08-01

Expected to finish

2025-07-01

Last updated by the study team

2023-10-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Able to provide written informed consent prior to screening
• Established diagnosis of small bowel or colonic Crohn's Disease (CD) or Ulcerative Colitis (UC)

You may not qualify if…

• Pregnant or breastfeeding
• Use of antibiotics within the last 3 months
• Bowel surgery in the past 3 months or planned bowel surgery during the 12-month study period

Where it is running

• Viome Life Sciences — Bothell, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.